Classification and definition of major flares in SLE clinical trials
- PMID: 10568907
- DOI: 10.1191/096120399680411281
Classification and definition of major flares in SLE clinical trials
Abstract
Multiple reliable and valid disease activities indices exist and have been used successfully in longitudinal studies. However, the definition of flare, using these intruments, has not been universally decided or accepted. Because flare is one of the three major patterns of lupus activity, it will remain an important outcome measure in both longitudinal and clinical trial studies.
Similar articles
-
Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.Arthritis Rheum. 1991 Aug;34(8):937-44. doi: 10.1002/art.1780340802. Arthritis Rheum. 1991. PMID: 1859487
-
Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365095 Review.
-
Outcome measures to be used in clinical trials in systemic lupus erythematosus.J Rheumatol. 1999 Feb;26(2):490-7. J Rheumatol. 1999. PMID: 9972993
-
Ensuring reliability of clinical assessments for SLE trials.Lupus. 1999;8(8):671-6. doi: 10.1191/096120399680411353. Lupus. 1999. PMID: 10568905
-
[Diagnostic problems and evaluation of disease activity in systemic lupus erythematosus].Przegl Lek. 2005;62(5):299-305. Przegl Lek. 2005. PMID: 16334536 Review. Polish.
Cited by
-
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.
-
Belimumab for systemic lupus erythematosus.Cochrane Database Syst Rev. 2021 Feb 25;2(2):CD010668. doi: 10.1002/14651858.CD010668.pub2. Cochrane Database Syst Rev. 2021. PMID: 33631841 Free PMC article.
-
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.Ann Rheum Dis. 2018 Mar;77(3):355-363. doi: 10.1136/annrheumdis-2017-211631. Epub 2018 Jan 2. Ann Rheum Dis. 2018. PMID: 29295825 Free PMC article. Clinical Trial.
-
Evaluating the concordance between BICLA and SRI4 in patients with systemic lupus erythematosus from the placebo arms of the EXPLORER and ATHOS trials.Lupus Sci Med. 2025 May 19;12(1):e001483. doi: 10.1136/lupus-2024-001483. Lupus Sci Med. 2025. PMID: 40389370 Free PMC article. Clinical Trial.
-
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.Arthritis Rheum. 2011 Dec;63(12):3918-30. doi: 10.1002/art.30613. Arthritis Rheum. 2011. PMID: 22127708 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical